… In conclusion, FDG PET/CT plays an important role in the staging of NSCLC, providing …
front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung …

… The α ν β 3 integrin plays a crucial role in the pathophysiological pathways of lung cancer.
Tripeptide of Arg-Gly-Asp (RGD) in combination with a radionuclide can selectively bind to …

… staging of the mediastinum is critical in the preoperative staging of non–small-cell lung
cancer … Few studies have evaluated the role of endoscopic staging in NSCLC patients with …

… staging in lung cancer in this study population. In particular, visual analysis in the dynamic
second phase may not show any false-positive findings, which can occur in the dynamic third …

… , 125 ovarian cancer, 126 and stage III basal cell carcinoma. Integrin α v β 6 … carcinoma,
128 non-small cell lung cancer, 129 cervical squamous carcinoma, 130 and gastric carcinoma. …

… Accurate staging of lung cancer is of utmost importance in determining the … glands and
18-fluoro-2 deoxyglucose positron emission tomography (PET)/CT scan facilitate the initial …

Background This study classifies lung adenocarcinoma (ADC) and squamous cell carcinoma
(SCC) using subregion-based radiomics features extracted from positron emission …

… Great advances in the management of lung cancer are based … nodules, (b) staging and
re-staging lung cancer, (c) guiding … reliable method for staging and re-staging lung cancer, and …

… , a whole body 18 F-deoxyglucose-positron emission tomography ( 18 FDG-PET) is advised
to … Our results stress the importance of adequate screening for BM in this patient population …

… We identified computational imaging features on 18F-fluorodeoxyglucose positron
emission tomography (PET) that predict recurrence/progression in non–small cell lung cancer (…